Biological and medical scientists have been using flow cytometry to count cancer cells for the past 40 years. But the large instruments are expensive and can only be operated by trained personnel. By contrast the PoCyton cytometer is cheap to produce, no bigger than a shoebox, and automated.
Scientists have created an enzyme that could potentially solve this problem. The enzyme works by snipping off the sugars, also known as antigens, found in Type A and Type B blood, making it more like Type O. Type O blood is known as the universal donor and can be given to patients of all blood types.
Students from the University of Cambridge have set up the world?s largest e-commerce platform for single stranded DNA which they believe have enormous potential for contributing to therapeutic treatments.
Researchers have developed a new computational method called AGGRESCAN3D which will allow studying in 3D the structure of folded globular proteins and substantially improve the prediction of any propensity for forming toxic protein aggregates. With this new algorithm proteins can also be modelled to study the pathogenic effects of the aggregation or redesign them for therapeutic means.
A team of Belgian philosophers and plant biotechnologists have turned to cognitive science to explain why opposition to genetically modified organisms (GMOs) has become so widespread, despite positive contributions GM crops have made to sustainable agriculture.